DexCom DXCM Stock
DexCom Price Chart
DexCom DXCM Financial and Trading Overview
| DexCom stock price | 130.69 USD |
| Previous Close | 127.06 USD |
| Open | 128.32 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 800 |
| Day's Range | 128.1 - 131.24 USD |
| 52 Week Range | 67.74 - 131.24 USD |
| Volume | 4.12M USD |
| Avg. Volume | 2.3M USD |
| Market Cap | 50.77B USD |
| Beta (5Y Monthly) | 1.144718 |
| PE Ratio (TTM) | 184.47887 |
| EPS (TTM) | 1.54 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 140.7 USD |
DXCM Valuation Measures
| Enterprise Value | 48.83B USD |
| Trailing P/E | 184.47887 |
| Forward P/E | 87.32 |
| PEG Ratio (5 yr expected) | 3.73 |
| Price/Sales (ttm) | 16.7982 |
| Price/Book (mrq) | 22.735636 |
| Enterprise Value/Revenue | 16.155 |
| Enterprise Value/EBITDA | 90.19 |
Trading Information
DexCom Stock Price History
| Beta (5Y Monthly) | 1.144718 |
| 52-Week Change | 90.35% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 131.24 USD |
| 52 Week Low | 67.74 USD |
| 50-Day Moving Average | 119.91 USD |
| 200-Day Moving Average | 110.25 USD |
DXCM Share Statistics
| Avg. Volume (3 month) | 2.3M USD |
| Avg. Daily Volume (10-Days) | 2.87M USD |
| Shares Outstanding | 387.64M |
| Float | 384.55M |
| Short Ratio | 5.58 |
| % Held by Insiders | 0.40% |
| % Held by Institutions | 100.06% |
| Shares Short | 14.26M |
| Short % of Float | 4.16% |
| Short % of Shares Outstanding | 3.67% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 4:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 9.67% |
| Operating Margin (ttm) | 13.13% |
| Gross Margin | 64.43% |
| EBITDA Margin | 17.91% |
Management Effectiveness
| Return on Assets (ttm) | 4.69% |
| Return on Equity (ttm) | 13.22% |
Income Statement
| Revenue (ttm) | 3.02B USD |
| Revenue Per Share (ttm) | 7.77 USD |
| Quarterly Revenue Growth (yoy) | 17.89% |
| Gross Profit (ttm) | 1.88B USD |
| EBITDA | 541.4M USD |
| Net Income Avi to Common (ttm) | 292.5M USD |
| Diluted EPS (ttm) | 0.71 |
| Quarterly Earnings Growth (yoy) | -50.10% |
Balance Sheet
| Total Cash (mrq) | 2.57B USD |
| Total Cash Per Share (mrq) | 6.62 USD |
| Total Debt (mrq) | 2.14B USD |
| Total Debt/Equity (mrq) | 95.96 USD |
| Current Ratio (mrq) | 2.02 |
| Book Value Per Share (mrq) | 5.761 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 753.9M USD |
| Levered Free Cash Flow (ttm) | 429.06M USD |
Profile of DexCom
| Country | United States |
| State | CA |
| City | San Diego |
| Address | 6340 Sequence Drive |
| ZIP | 92121 |
| Phone | 858 200 0200 |
| Website | https://www.dexcom.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 7500 |
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices for specific and permitted use cases, including non-medical device applications, medical device data analysis, integrated continuous glucose monitoring systems (iCGM) secondary display alarms, active patient monitoring, and treatment decisions; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.
Q&A For DexCom Stock
What is a current DXCM stock price?
DexCom DXCM stock price today per share is 130.69 USD.
How to purchase DexCom stock?
You can buy DXCM shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for DexCom?
The stock symbol or ticker of DexCom is DXCM.
Which industry does the DexCom company belong to?
The DexCom industry is Medical Devices.
How many shares does DexCom have in circulation?
The max supply of DexCom shares is 397.68M.
What is DexCom Price to Earnings Ratio (PE Ratio)?
DexCom PE Ratio is 84.86364000 now.
What was DexCom earnings per share over the trailing 12 months (TTM)?
DexCom EPS is 1.54 USD over the trailing 12 months.
Which sector does the DexCom company belong to?
The DexCom sector is Healthcare.
DexCom DXCM included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16794.88 USD — |
+0.65
|
6.83B USD — | 16695.69 USD — | 16823.83 USD — | — - | 6.83B USD — |
| S&P 500 INDEX SPX | 5308.13 USD — |
+0.09
|
1.84B USD — | 5302.4 USD — | 5325.32 USD — | — - | 1.84B USD — |
| S&P 500 (Yahoo.com) GSPC | 5308.13 USD — |
+0.09
|
1.83B USD — | 5302.4 USD — | 5325.32 USD — | — - | 1.83B USD — |
| US100 NDX | 18674.19 USD — |
+0.69
|
650.62M USD — | 18549.84 USD — | 18703.83 USD — | — - | 650.62M USD — |
| Nasdaq-100 Micro Index XND | 186.74 USD — |
+0.69
|
— — | 185.5 USD — | 187.04 USD — | — - | — — |
| NASDAQ 100 After Hours Indicato QIV | 18660.85 USD — |
+0.62
|
— — | 18653.67 USD — | 18682.53 USD — | — - | — — |
| NQ US Medical Supplies Large M NQUSB4537LMN | 3087.37 USD — |
<0.01
|
— — | 3057.02 USD — | 3124.33 USD — | — - | — — |
| Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG | 2653.43 USD — |
+0.58
|
— — | 2641.29 USD — | 2657.82 USD — | — - | — — |
| NASDAQ 100 Ex Tech Sector NDXX | 5317.3 USD — |
+0.04
|
— — | 5295.33 USD — | 5321.9 USD — | — - | — — |
| Nasdaq-100 ESG JPY Index NDXESG07 | 1951.52 JPY 13.17 USD |
+1.32
|
— — | 1936.26 JPY 13.07 USD | 1955.9 JPY 13.2 USD | — - | — — |
| NASDAQ-100 PM Settlement Value XQC | 16331.98 USD — |
+1.13
|
— — | 16331.98 USD — | 16331.98 USD — | — - | — — |
| NASDAQ 100 Notional Net Total R XNDXNNR | 21518.85 USD — |
+0.69
|
— — | 21375.56 USD — | 21553.01 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 1001.25 USD — |
+0.4
|
— — | 995.47 USD — | 1002.74 USD — | — - | — — |
| NASDAQ Composite Total Return I XCMP | 20429.99 USD — |
+0.66
|
— — | 20309.34 USD — | 20465.21 USD — | — - | — — |
| NASDAQ 100 Pre Market Indicator QMI | 18555.57 USD — |
+0.05
|
— — | 18553.6 USD — | 18603.7 USD — | — - | — — |
- {{ link.label }} {{link}}